[PDF][PDF] Tau kinetics in neurons and the human central nervous system

…, MJ Crisp, T Kasten, KM Kirmess, NM Kanaan… - Neuron, 2018 - cell.com
We developed stable isotope labeling and mass spectrometry approaches to measure the
kinetics of multiple isoforms and fragments of tau in the human central nervous system (CNS) …

Axonal transport defects in neurodegenerative diseases

GA Morfini, M Burns, LI Binder, NM Kanaan… - Journal of …, 2009 - Soc Neuroscience
Adult-onset neurodegenerative diseases (AONDs) comprise a heterogeneous group of
neurological disorders characterized by a progressive, age-dependent decline in neuronal …

Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates

TJ Collier, NM Kanaan, JH Kordower - Nature Reviews Neuroscience, 2011 - nature.com
Ageing is the greatest risk factor for the development of Parkinson's disease. However, the
current dogma holds that cellular mechanisms that are associated with ageing of midbrain …

[HTML][HTML] Liquid-liquid phase separation induces pathogenic tau conformations in vitro

NM Kanaan, C Hamel, T Grabinski, B Combs - Nature communications, 2020 - nature.com
Formation of membrane-less organelles via liquid-liquid phase separation is one way cells
meet the biological requirement for spatiotemporal regulation of cellular components and …

Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration

…, KC Luk, FP Manfredsson, NM Kanaan… - Neurobiology of …, 2015 - Elsevier
Previous studies demonstrate that intrastriatal injections of fibrillar alpha-synuclein (α-syn)
into mice induce Parkinson's disease (PD)-like Lewy body (LB) pathology formed by …

[HTML][HTML] Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease

…, C Remmers, Y Fu, S Brooker, NM Kanaan… - Journal of Biological …, 2011 - ASBMB
Neurofibrillary tangles, composed of insoluble aggregates of the microtubule-associated
protein Tau, are a pathological hallmark of Alzheimer disease (AD) and other tauopathies. …

Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases

NM Kanaan, GA Morfini, NE LaPointe… - Journal of …, 2011 - Soc Neuroscience
Aggregated filamentous forms of hyperphosphorylated tau (a microtubule-associated protein)
represent pathological hallmarks of Alzheimer's disease (AD) and other tauopathies. While …

Aging and Parkinson's disease: Different sides of the same coin?

TJ Collier, NM Kanaan, JH Kordower - Movement Disorders, 2017 - Wiley Online Library
Despite abundant epidemiological evidence in support of aging as the primary risk factor for
PD, biological correlates of a connection have been elusive. In this article, we address the …

Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo

…, C Zhang, CY Ung, Y Tripodis, NM Kanaan… - Nature …, 2018 - nature.com
Emerging studies suggest a role for tau in regulating the biology of RNA binding proteins (RBPs).
We now show that reducing the RBP T-cell intracellular antigen 1 (TIA1) in vivo …

Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system

NM Kanaan, GF Pigino, ST Brady, O Lazarov… - Experimental …, 2013 - Elsevier
Alzheimer's disease (AD) is characterized by progressive, age-dependent degeneration of
neurons in the central nervous system. A large body of evidence indicates that neurons …